The team of Marc DALOD, CNRS Team Leader at the Centre d'Immunologie de Marseille-Luminy, CNRS, Inserm and Aix-Marseille University, in collaboration with a team from "The Tisch Cancer Institute", Icahn School of Medicine at Mount Sinai in New York, has found a way to artificially generate a type of immune cell that could help make dendritic cell vaccines, a promising type of immunotherapy, more effective. This study is published in Cell Reports on August 14, 2018.
Balan S. et al., Cell Rep., , Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity
See Media Marc Dalod interview
Team
